"Qatar Pharmaceuticals & Healthcare Report Q2 2016" now available at Fast Market Research

Qatar's pharmaceuticals and healthcare sectors will continue to grow despite challenges facing the government's revenue streams. Both an increase in public spending on health, including in infrastructure projects, and the rising participation of the private sector in healthcare funding will sustain robust sector growth over the forecast period . In fact, w hile Qatar will likely remain on track with its development objectives to become a major healthcare player in the region , the rising demand for healthcare, which is in part driven by the growing prevalence of chronic diseases, will support renewed opportunities for drugmakers.

Full Report Details at
- http://www.fastmr.com/prod/1152875_qatar_pharmaceuticals.aspx?afid=301

Headline Expenditure Projections

Pharmaceuticals: QAR1.91bn (USD524mn) in 2015 to QAR2.04bn (USD559mn) in 2016; +6.8% in local currency and US dollar terms. Forecast unchang ed from last quarter .
Healthcare: QAR18.49bn (USD5.08bn) in 2015 to QAR19.85bn (USD5.45bn) in 2016; +7.3% in both local currency and US dollar terms. Forecast revised slightly downwards from last quarter .

Risk/Reward Index

In Q216, we have revised downwards Qatar's Risk/Reward Index score to 53.6 from 55.5 previously (out of 100). Qatar's score revision was mainly driven by lower industry and country rewards indices. Qatar shifted down one ranking position to fifth out of 31 markets in the Middle East and Africa region in terms of attractiveness to pharmaceutical investors. Qatar's score is driven by high spending per capita on medicine and high sector value growth, but is dragged down by a small market size and a small pensionable population.

Latest Updates

Despite cutbacks to other sectors in the Qatari government's 2016 budget, healthcare spending is set to rise to QAR16.4bn (USD4.5bn) in the same year, up from QAR15.5bn (USD4.2bn) in 2015, while several healthcare capital projects have been highlighted by the government, such as increased funding to the Sidra Medical and Research Center, the set up of five new health centres and a cancer treatment centre, and the completion of Hamad General Hospital and Hamad Medical City.

According to Qatar's Supreme Council of Health annual report, 11 new hospitals and medical research facilities are anticipated to be established in the country by 2022, including the USD635mn Hamad Bin Khalifa Medical City.

Against this background, and rising healthcare spending figures, the Supreme Council of Health confirmed that Qatar's National Health Strategy 2011-2016 is on track to achieve the health objectives set in the National Vision 2030, which confirms Qatar's increased focus on healthcare and in achieving its aim of becoming a major healthcare player in the region.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)